Mechanism(s) Underlying Hypotensive Response to ARB/NEP Inhibition - Aim 1
Clinical trial NCT03738878 · TERMINATED
Trial details
- NCT number
- NCT03738878
- Sponsor
- Vanderbilt University Medical Center
- Status
- TERMINATED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-15
- Primary completion
- 2024-12-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.